Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Protection against recurrent genital herpes by therapeutic immunization with herpes simplex virus type 2 ribonucleotide reductase protein subunits

Protection against recurrent genital herpes by therapeutic immunization with herpes simplex virus type 2 ribonucleotide reductase protein subunits

US Patent 11213582 · Granted Jan 4, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Immunogenic peptides for treatment of herpes simplex virus infection and conditi2018